← SynDRA
SEL-120 FREE BASE
SynDRA canonical compound SYN0039339 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | CDK19 | CDK8 |
|---|
| Mechanism of action | cdk inhibitor |
|---|
| Indication | acute myeloid leukemia (aml) |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
Mechanisms of action (all sources)
- CDK19 INHIBITOR
- CDK8 INHIBITOR
- cyclin-dependent kinase inhibitor
Cross-references
Synonyms
- Romaciclib
- UNII-6LGR0RYY5Q
- SEL120-34A free base
- CDK8-IN-2 free base
- 6LGR0RYY5Q
- RefChem:182254
- SEL120-34A
- romaciclib [INN]
- SEL120-34Afree
- CDK8-IN-2
- C15H18Br2N4
- orb1710104
- RVU120
- SCHEMBL17106044
- SCHEMBL29372569
- GTPL13753
- GLXC-90225
- EX-A2929
- JPC52233
- SEL-120-34A
- BDBM50459995
- MFCD31619286
- NSC805500
- AKOS040732774
- NSC-805500
- NCGC00590966-01
- AC-31560
- TS-07724
- HY-111388
- CS-0040310
- T10744
- s8840
- SEL120(SEL120-34,SEL120-34A)
- SE-120-34A
- SEL120-34A hydrochloride
- T10744L
- CS-0041061
- C15H19Br2ClN4
Look up SEL-120 FREE BASE in the interactive SynDRA portal →